Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FLT3 | P36888 | 3/20 | 0.59 |
| ▸ | PDGFRB | P09619 | 3/20 | 0.53 |
| ▸ | PDGFRA | P16234 | 2/20 | 0.53 |
| ▸ | DRD3 | P35462 | 13/20 | 0.52 |
| ▸ | DRD2 | P14416 | 9/20 | 0.52 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.45 |
| ▸ | HTR1A | P08908 | 1/20 | 0.45 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.45 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.45 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7879718 | 0.95 | FLT3 (0.54) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| SCHEMBL7879728 | 0.85 | FLT3 (0.43) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| SCHEMBL7882051 | 0.85 | FLT3 (0.48) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| Hydrochloric Acid SCHEMBL7881414 | 0.84 | FLT3 (0.42) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| Hydrochloric Acid SCHEMBL7877871 | 0.83 | DRD3 (0.43) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| SCHEMBL7877830 | 0.83 | DRD3 (0.46) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| SCHEMBL7880874 | 0.83 | RXFP1 (0.42) | FLT3 | |
| Hydrochloric Acid SCHEMBL8628104 | 0.83 | FLT3 (0.41) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| Hydrochloric Acid SCHEMBL7879744 | 0.83 | FLT3 (0.41) | FLT3PDGFRBPDGFRADRD3DRD2 | |
| SCHEMBL7884296 | 0.82 | KDR (0.40) | FLT3PDGFRBPDGFRADRD3DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6248772-B1 | HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS | SUMITOMO PHARMACEUTICALS CO., LTD. (JP) | 2001-06-19 | — | — | US | disclosed |
| US-6169107-B1 | USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS | SUMITOMO PHARMACEUTICAL CO., LTD. (JP) | 2001-01-02 | — | — | US | disclosed |
| EP-0622356-B1 | Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange | SUMITOMO PHARMA (JP) | 1998-07-01 | — | — | EP | disclosed |
| EP-0708091-A2 | Indoloylguanidine derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-04-24 | — | — | EP | disclosed |
| EP-0622356-A1 | Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1994-11-02 | — | — | EP | disclosed |